Wolverine Trading, LLC Bluebird Bio, Inc. Transaction History

Wolverine Trading, LLC

$94.2 Billion
Q2 2024

A detailed history of Wolverine Trading, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 26,600 shares of BLUE stock, worth $13,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,600

Previous 19,468 36.63%

Holding current value

$13,832

Previous $24,000 8.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.91 - $1.75 $23,557 - $45,302	-25,887 Reduced 57.08%	19,468 $24,000
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $26,657 - $97,541	20,195 Added 80.27%	45,355 $62,000
Q3 2023 Nov 15, 2023	BUY	$3.02 - $4.05 $16,866 - $22,619	5,585 Added 28.53%	25,160 $76,000
Q2 2023 Aug 23, 2023	SELL	$2.79 - $5.03 $10,998 - $19,828	-3,942 Reduced 16.76%	19,575 $64,000
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $35,434 - $92,762	11,285 Added 92.26%	23,517 $74,000
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $6,877 - $10,120	1,192 Added 10.8%	12,232 $85,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $41,400 - $81,585	11,040 New	11,040 $63,000
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $101,700 - $180,916	-34,592 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $140,789 - $366,675	34,592 New	34,592 $171,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $93,739 - $170,635	-10,462 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $131,609 - $245,889	-11,709 Reduced 52.81%	10,462 $199,000
Q2 2021 Aug 06, 2021	SELL	$18.04 - $22.09 $659,181 - $807,168	-36,540 Reduced 62.24%	22,171 $667,000
Q1 2021 May 14, 2021	BUY	$16.59 - $33.89 $758,644 - $1.55 Million	45,729 Added 352.25%	58,711 $1.68 Million
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $116,166 - $147,568	-3,373 Reduced 20.62%	12,982 $714,000
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $187,534 - $317,882	6,915 Added 73.25%	16,355 $983,000
Q1 2020 May 11, 2020	SELL	$26.16 - $63.5 $31,235 - $75,819	-1,194 Reduced 11.23%	9,440 $443,000
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $3,925 - $6,144	-66 Reduced 0.62%	10,634 $987,000
Q2 2019 Aug 20, 2019	BUY	$75.84 - $105.21 $811,488 - $1.13 Million	10,700 New	10,700 $1.36 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $1.59 Million - $2.51 Million	-26,868 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $1.22 Million - $1.61 Million	13,730 Added 104.51%	26,868 $3.92 Million
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $1.29 Million - $1.84 Million	-12,195 Reduced 48.14%	13,138 $2.24 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $1.75 Million - $2.82 Million	21,586 Added 576.09%	25,333 $4.51 Million
Q3 2017 Nov 15, 2017	BUY	$57.74 - $91.42 $216,351 - $342,550	3,747	3,747 $515,000

Others Institutions Holding BLUE

# of Institutions

162

Shares Held

79.9M

Call Options Held

525K

Put Options Held

634K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $40.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Bluebird Bio, Inc. Transaction History